Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Stemgent
3157
Stemgent
Technology
Biotechnology
Stemgent is a leading supplier providing mRNA reprogramming systems, cell culture media, antibodies, small molecules, and iPS reprogramming services.
Suggest edits
Founded
2008
Raised
$16.7M
Follow us
Companies in the same industry
CrossRoads Extremity Systems
Longevity Biotech
Binhui Biotech
United Health - Beijing Zhongliankang Biological Technology
3D Medicines
Twentyeight-Seven Therapeutics
FirstString Research
AgroSustain
Amarna Therapeutics
Jasper Therapeutics
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$2,700,000
Debt financing - 2009
Morgenthaler Ventures
HealthCare Ventures
$14,000,000
Venture capital (Series B) - 2009
Morgenthaler Ventures
Frazier Healthcare Partners
Team Size
50+
Employees
I work here
Location
United States
Headquarters
Explore United States
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Stemgent makes some noise.
